Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Index movements reflect changes in component stock prices, earnings, macro data, and capital flows. This overview highlights the main drivers behind daily swings.
18,176 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Shopify delivered strong quarterly results, but the stock traded lower as guidance softened. This article explains wh...
MicroStrategy holds a record bitcoin stash worth more than its market value, yet MSTR stock is down sharply over the ...
Investors woke up to a surprising move in CoreWeave stock Monday. The rally hinges on a trail of AI hardware mileston...
Investors are buzzing about QuantumScape after news of a major automaker collaboration. This article breaks down what...
CoreWeave stock tumbling today underscores the volatility in AI infrastructure plays. This explainer breaks down what...
When a CEO sells shares, investors watch closely. This piece breaks down Exponent's move by Catherine Corrigan, expla...
A single quarterly filing can rewrite a fund’s star players. Tepper’s Appaloosa appears to have shifted away from NVI...
A new stake in Vista Energy signals rising institutional interest in the energy sector. This article breaks down why ...
Andersen Group surged on surprise Q4 strength and an optimistic outlook. This deep dive explains what drove the rally...
When a senior executive at Maze Therapeutics sells a stake after positive trial data and solid quarterly results, inv...
When a company reports Q1 2026 results, the earnings call is where plans meet numbers. This guide explains how to rea...